How PhRMA finally lost: the inside story of the group’s biggest lobbying failure in years

(By Nicholas Florko for STAT)

WASHINGTON —The drug industry’s storied lobbying group isn’t accustomed to bad news — and with its small army of well connected advocates, it’s even less familiar with surprises.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.